Rapamycin and RA: Low-dose sirolimus immunoregulatory therapy selectively upregulated Tregs and partly replaced the usage of immunosuppressants to control disease activity without overtreatment and evaluable side effects (J Immunol Res. 2019)
4 Likes
sirolimus at a dosage of 0.5 mg on alternate days for 24 weeks
2 Likes